MAYNF (Mayne Pharma Group) Tariff Resilience Score: 6/10 (As of Jun. 30, 2026)


MAYNF Mayne Pharma Group Ltd MAYNF
48 GF Score
Price $1.65
GF Value $3.41
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mayne Pharma Group Tariff Resilience Score?

Mayne Pharma Group MAYNF 48 Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus rates MAYNF with a GF Score™ of 48/100 and a GF Value™ of $3.41 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, Mayne Pharma Group ranks better than 94.96% on this metric.

Mayne Pharma Group has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Mayne Pharma Group has Pharmaceuticals often face fewer tariffs, but global supply chain dependencies can pose risks. Mayne Pharma's international operations may offer some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Mayne Pharma Group might have Average Resilient.

Mayne Pharma Group  (OTCPK:MAYNF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Mayne Pharma Group Tariff Resilience Score Related Terms

MAYNF vs MCK, CAH, COR: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, Mayne Pharma Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Mayne Pharma Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Tariff Resilience Score falls into.


MAYNF
48GF Score
Mayne Pharma Group Ltd MAYNF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Mayne Pharma Group (MAYNF) has a Tariff Resilience Score of 6 as of Jun. 30, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Mayne Pharma Group ranks #6 out of 119 companies in the Medical Distribution industry, placing it in the top 5%.
Is Mayne Pharma Group's Tariff Resilience Score too high?
Mayne Pharma Group's current Tariff Resilience Score is 6. Based on the distribution chart, Mayne Pharma Group ranks #6 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Mayne Pharma Group has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's Tariff Resilience Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Mayne Pharma Group ranks #6 out of 119 companies for Tariff Resilience Score. This places Mayne Pharma Group in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Mayne Pharma Group's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.41, compared to a current price of $1.65 — trading 51.6% below its estimated fair value. The current Tariff Resilience Score is 6. Mayne Pharma Group's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayne Pharma Group (MAYNF) Overvalued in 2026?

Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued. The current stock price of $1.65 is trading 51.6% below its estimated GF Value™ of $3.41. GuruFocus considers Mayne Pharma Group to be Possible Value Trap.

Key valuation signals for MAYNF:

  • Tariff Resilience Score: 6
  • GF Value™: $3.41 vs. price of $1.65 (51.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mayne Pharma Group Business Description

Other Exchanges MYX:Australia
Address 1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
48GF Score

Get the complete analysis for MAYNF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.65
Price
$3.41
GF Value